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Viral DNA sensing within the cytosol of infected cells
activates type I interferon (IFN) expression. MITA/
STING plays an essential role in this pathway by
acting as both a sensor for the second messenger
cGAMP and as an adaptor for downstream signaling
components. In an expression screen for proteins
that can activate the IFNB1 promoter, we identified
the ER-associated protein ZDHHC1 as a positive
regulator of virus-triggered, MITA/STING-dependent
immune signaling. Zdhhc1/ cells failed to effec-
tively produce IFNs and other cytokines in response
to infectionwith DNAbut not RNA viruses.Zdhhc1/
mice infected with the neurotropic DNA virus HSV-1
exhibited lower cytokine levels and higher virus titers
in the brain, resulting in higher lethality. ZDHHC1
constitutively associated with MITA/STING and me-
diates dimerization/aggregation of MITA/STING and
recruitment of the downstream signaling compo-
nents TBK1 and IRF3. These findings support a role
for ZDHHC1 in mediating MITA/STING-dependent
innate immune response against DNA viruses.
INTRODUCTION
Innate immune response is critical for efficient host
defense against viral infection. Upon viral infection, structurally
conserved viral components called pathogen-associated mo-
lecular patterns (PAMPs) are recognized by pathogen recogni-
tion receptors (PRRs) in the cell, which initiates a series of
signaling events that lead to the production of type I interferons
(IFNs) (including IFN-b and IFN-a family members), proinflamma-
tory cytokines, and other downstream antiviral effecter proteins.
These downstream cytokines and effecters act to inhibit viral
replication, eradicate virus-infected cells, and facilitate the initi-
ation of adaptive immune response (Akira et al., 2006; Hiscott,
2007; Janeway and Medzhitov, 2002; Paludan and Bowie,
2013; Seth et al., 2006; Wilkins and Gale, 2010).
The host cells have developed different mechanisms for
recognition of viral nucleic acids, which is the first step of innate450 Cell Host & Microbe 16, 450–461, October 8, 2014 ª2014 Elsevieantiviral response. Among PRRs, certain Toll-like-receptors
(TLRs) and RIG-I-like receptors (RLRs) are known to detect viral
RNA (Akira et al., 2006). For example, TLR3 recognizes viral dou-
ble-stranded RNA (dsRNA) released by infected cells, whereas
RIG-I and MDA5 sense viral RNA in the cytoplasm (Akira et al.,
2006). In addition to the viral RNA sensors, several proteins
have been reported to recognize viral DNA, including TLR9
(Lund et al., 2003), AIM2 (Bu¨rckstu¨mmer et al., 2009), DAI
(Takaoka et al., 2007), RNA polymerase III (Chiu et al., 2009),
IFI16 (Unterholzner et al., 2010), DDX41 (Zhang et al., 2011),
and LSm14A (Li et al., 2012). Various studies have demonstrated
that these proteins are important for innate immune responses
against various DNA viruses in distinct cell or mouse models.
For example, it has been shown that IFI16 is a sensor for HIV
DNA and required for CD4 T cell depletion following HIV infection
(Horan et al., 2013; Jakobsen and Paludan, 2014; Unterholzner
et al., 2010). However, studies have demonstrated that these
proteins are not universally required for detecting viral DNA in
distinct cell types or in vivo (Paludan and Bowie, 2013). Recently,
a nucleotidyltransferase family member, called cyclic GMP-AMP
(cGAMP) synthase (cGAS), has been identified to detect cyto-
solic DNA in various cell types (Sun et al., 2013). Gene knockout
studies demonstrate that cGAS is essential for innate immune
response against DNA viruses in cells and mice (Li et al., 2013;
Schoggins et al., 2014), suggesting that cGAS is a widely
used viral DNA sensor. Recently, studies with cGas/ cells
and mice suggest that cGAS also plays a role in innate immune
response against the single-stranded RNA (ssRNA) virus West
Nile virus (WNV), though it is unknown whether cGAS directly
senses viral RNA or regulates basal immune response (Schog-
gins et al., 2014).
Recognition of viral DNA by cGAS leads to the synthesis of the
secondmessenger cGAMP fromATP andGTP (Civril et al., 2013;
Sun et al., 2013; Wu et al., 2013). Synthesized cGAMP binds to
MITA (also called STING, MPYS, and ERIS), a critical adaptor
in virus-triggered IFN induction pathways and innate antiviral re-
sponses (Abe et al., 2013; Ishikawa and Barber, 2008; Ouyang
et al., 2012; Shu et al., 2012; Zhang et al., 2013; Zhong et al.,
2008). MITA is a 379 amino acid (aa) protein, which is consisted
of the N-terminal four transmembrane domains (aa 1–137) and
the C-terminal domain (CTD, aa 138–397). MITA anchors itself
in the ER, mitochondria and mitochondrial-associated mem-
brane via its N-terminal transmembrane domains, while its
CTD hangs in the cytosol to bind the secondmessenger cGAMP.r Inc.
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signaling to downstream through its C-terminal tail (CTT, aa 340–
379), which serves as a scaffold to assemble IRF3 in close prox-
imity to TBK1, leading to TBK1-dependent phosphorylation of
IRF3 and induction of downstream genes (Tanaka and Chen,
2012; Zhong et al., 2008). Gene knockout studies demonstrate
that deficiency of MITA impairs type I IFN induction triggered
by DNA viruses such as herpes simplex virus-1 (HSV-1) and viral
clearance in mice (Ishikawa et al., 2009). Although it is widely
accepted that MITA is required for type I IFN induction triggered
by DNA viruses in mice, whether MITA plays a role in innate im-
mune responses against RNA viruses is still unresolved. Several
studies have demonstrated a role of MITA in type I IFN induction
triggered by RNA viruses, including Sendai virus (SeV) and vesic-
ular stomatitis virus (VSV) in certain human cell lines (Ishikawa
and Barber, 2008; Ishikawa et al., 2009; Sun et al., 2009; Zhong
et al., 2008). In addition, induction of type I IFNs triggered
by VSV infection is reduced to 20% in Mita/ mice (Ishikawa
and Barber, 2008; Ishikawa et al., 2009). However, induction of
type I IFNs in the serum triggered by encephalomyocarditis virus,
also an RNA virus, is not affected inMita/mice (Ishikawa et al.,
2009). It is possible that MITA is involved in innate immune
responses against RNA viruses in a virus- and cell-type-specific
manner.
In this study, we identified ZDHHC1, an ER-associated
protein, as a mediator for type I IFN induction in expression
screens. Gene knockout studies suggest that ZDHHC1 defi-
ciency impaired production of type I IFNs and other cytokines
in response to infection with DNA viruses. Consistently,
Zdhhc1/ mice were more susceptible to lethal infection by
HSV-1. ZDHHC1 was constitutively associated with MITA and
important for dimerization/aggregation of MITA and recruitment
of downstream components TBK1 and IRF3 to MITA. Our find-
ings suggest that ZDHHC1 plays an important role in innate im-
mune response against DNA viruses bymodulatingMITA activity
and provide important insights into the delicate regulatory mech-
anisms of innate immune response against DNA viruses.
RESULTS
Identification of ZDHHC1 as a Positive Regulator of
Virus-Triggered Signaling
Virus-triggered induction of type I IFNs is delicately regulated to
ensure proper but not excessive innate immune response. To
further elucidate the mechanisms of virus-triggered IFN induc-
tion, we performed expression screens to unambiguously iden-
tify proteins that can activate the IFN-b promoter. These efforts
led to the identification of ZDHHC1, a member of the aspar-
tate-histidine-histidine-cysteine (DHHC) palmitoyl acytransfer-
ase family, which could markedly activate the IFN-b promoter
in reporter assays (Figures S1A and S1B available online).
Further experiments indicated that overexpression of ZDHHC1
activated the IFN-b promoter in a dose-dependent manner in
HeLa cells (Figure 1A). Previously, it has been demonstrated
that induction of IFN-b requires cooperation of two transcription
factors, IRF3 and NF-kB (Maniatis et al., 1998). Consistently,
overexpression of ZDHHC1 activated ISRE (an enhancer motif
for IRF3) and NF-kB in a dose-dependent manner in reporter
assays (Figure 1A). Overexpression of ZDHHC1 also inducedCell HosIRF3 phosphorylation dose dependently (Figure S1C). Overex-
pression of ZDHHC1 also dramatically potentiated activation of
the IFN-b promoter triggered by transfection of synthetic viral
RNA analog poly(I:C) or B-DNA (Figure 1B) or by infection with
HSV-1 and SeV in human HeLa cells (Figure 1C). Overexpression
of ZDHHC1 also dramatically potentiated ISRE and NF-kB acti-
vation triggered by both HSV-1 and SeV (Figure S1D). These
results suggest that ZDHHC1 is involved in virus-triggered in-
duction of IFN-b.
ZDHHC1 is a member of the DHHC palmitoyl transferase
family. Specific aspartate-histidine (DH) and cysteine (C) resi-
dues in the DHHC domain of ZDHHC1 are important for its pal-
mitoyl transferase activity (Korycka et al., 2012; Sharma et al.,
2008). To determine whether the palmitoyl transferase activity
of ZDHHC1 is required for its ability to mediate IFN-b induc-
tion, the conserved D161H162 or C164 of ZDHHC1 was sepa-
rately mutated. Reporter assays indicated that these mutants
activated the IFN-b promoter and potentiated SeV- and HSV-
1-triggered activation of the IFN-b promoter to similar levels as
wild-type ZDHHC1 (Figure S1E), suggesting that the palmitoyl
transferase activity is not required for its function in virus-trig-
gered IFN-b induction.
To determine whether endogenous ZDHHC1 is important for
virus-triggered IFN-b induction, we first examined the expres-
sion levels of ZDHHC1 in several cell lines. RT-PCR and immuno-
blot analysis indicated that ZDHHC1 was similarly expressed
in all examined cell lines, including HEK293, HEK293T, HeLa,
THP1, andMita/mouse dendritic cell (DC), except Zdhhc1/
mouse DC (Figure S1F and S1G). In these experiments, MITA
was found to be expressed in THP1, HeLa, HCT116, HEK293,
and mouse Zdhhc1/ DC but not in Mita/ mouse DC (Fig-
ure S1F and S1G). MITA expression was barely detectable in
HEK293T cells in these experiments (Figure S1G). In addition,
cGAS was also found to be ubiquitously expressed in these
examined cells (Figure S1F and S1G). To investigate the func-
tions of ZDHHC1, we performed RNAi-mediated knockdown
experiments in HeLa cells (Figure 1D). Reporter assays indicated
that knockdown of ZDHHC1 inhibited activation of the IFN-b pro-
moter triggered by transfected poly(I:C) and B-DNA in these cells
(Figure 1E). Similarly, knockdown of ZDHHC1 also inhibited
HSV-1- and SeV-triggered expression of the IFNB1 in HeLa cells
(Figure 1F). Noticeably, ZDHHC1 knockdown was less effective
in inhibition of poly(I:C)- or SeV-triggered than B-DNA- or HSV-
1-triggered induction of IFN-b in these experiments. In similar
experiments, knockdown of ZDHHC1 had no inhibitory effects
on TLR3-mediated activation of the IFN-b promoter triggered
by extracellular stimulation of the 293-TLR3 cells with poly(I:C)
(Figure S1H). These data suggest that ZDHHC1 specifically
mediates virus-triggered and cytoplasmic receptor-mediated
induction of IFN-b.
ZDHHC1 Is Essential for DNA but Not RNA
Virus-Triggered Signaling in Murine Cells
Human ZDHHC1 is consisted of 485 aa residues and shares
98% sequence identity with its murine ortholog. To investigate
the functions of ZDHHC1 in innate antiviral response, we gener-
ated ZDHHC1-deficient mice by a conventional gene-target-
ing method (Figures S2A–S2C). Zdhhc1/ mice were viable,
grossly normal, and reproductive, suggesting that ZDHHC1 ist & Microbe 16, 450–461, October 8, 2014 ª2014 Elsevier Inc. 451
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Figure 1. Identification of ZDHHC1 as a Positive Regulator of Virus-Triggered Signaling
(A) ZDHHC1 activates the IFN-b promoter in a dose-dependent manner. HeLa cells (1 3 105) were transfected with the indicated reporter plasmid (0.1 mg) and
increased amounts of ZDHHC1expression plasmid (0.05, 0.1, and 0.2 mg). Luciferase assays were performed 24 hr after transfection.
(B) ZDHHC1 potentiates poly(I:C)-, B-DNA-induced activation of the IFN-b promoter. HeLa cells (13 105) were transfected with the IFN-b promoter plasmid and
the indicated plasmid (0.1 mg) for 20 hr and then further transfected with poly(I:C) (0.5 mg) and B-DNA (0.5 mg) for 18 hr before luciferase assays were performed.
(C) ZDHHC1 potentiates SeV- and HSV-1-induced activation of the IFN-b promoter. HeLa cells (13 105) were transfected with the IFN-b promoter plasmid and
the indicated plasmid (0.1 mg) for 20 hr, cells were then left untreated or infected with SeV or HSV-1 for 12 hr before luciferase assays were performed.
(D) Effects of ZDHHC1-RNAi plasmids on endogenous ZDHHC1. HeLa cells (1 3 107) were transfected with the indicated RNAi plasmids (10 mg), and immu-
noblots were performed with the indicated antibodies.
(E) Effects of ZDHHC1-RNAi plasmids on poly(I:C)- and B-DNA-induced activation of the IFN-b promoter. HeLa cells (1 3 105) were transfected with the IFN-b
promoter plasmid (0.1 mg) and the indicated RNAi plasmids (1 mg) for 24 hr, followed by further transfection of the indicated nucleic acids for 20 hr before luciferase
assays were performed.
(F) Effects of ZDHHC1-RNAi plasmids on SeV- and HSV-1-induced expression of IFNB1. HeLa cells (23 105) were transfected with the indicated RNAi plasmids
(2 mg). Twenty-four hours after transfection, cells were left untreated or infected with SeV or HSV-1 for 12 hr before quantitative PCR (qPCR) analysis.
Graphs show mean ± SD, n = 3. See also Figure S1.
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numbers and compositions of major immune cells in lymph
nodes, spleen, and thymus were similar between Zdhhc1/
and Zdhhc1+/+ mice (Figure S2E), suggesting that ZDHHC1 is
not essential for development of the examined immune cells.
To investigate the roles of ZDHHC1 in innate immune
response, we compared expression of downstream genes
induced by synthetic nucleic acids transfected into Zdhhc1/
and Zdhhc1+/+ mouse embryonic fibroblasts (MEFs). Previously,
it has been demonstrated that in addition to B-DNA, trans-
fected dsDNA (120-mers) representing the genomes of HSV-1
(HSV120), dsDNA of approximately 90 bp (dsDNA90), and pol-
y(dG:dC) were efficient at inducing the expression of type I
IFNs (Abe et al., 2013; Ishikawa et al., 2009). As shown in Fig-
ure 2A and 2B, the levels of Ifnb1, Isg56, and Il6 mRNAs, as
well as the secreted IFN-b, TNFa, and IL6 proteins, were mark-
edly lower in Zdhhc1/ in comparison to Zdhhc1+/+ MEFs
following transfection of the synthetic DNAs. Unexpectedly, the
mRNA levels of these downstream genes induced by the syn-
thetic dsRNA analog poly(I:C) were similar in Zdhhc1/ and
Zdhhc1+/+ MEFs (Figure 2A). Consistently, the levels of Ifnb1,
Isg56, and Il6 mRNAs induced by the DNA virus HSV-1 were452 Cell Host & Microbe 16, 450–461, October 8, 2014 ª2014 Elseviemarkedly lower in Zdhhc1/ in comparison to Zdhhc1+/+
MEFs (Figure 2C). In these experiments, the mRNA levels of
these downstream genes induced by the RNA viruses SeV and
VSV were similar between Zdhhc1/ and Zdhhc1+/+ MEFs (Fig-
ure 2C). These results suggest that endogenous ZDHHC1 plays
an important role in DNA- but not RNA-virus-triggered induction
of downstream antiviral genes in MEFs. To confirm the roles of
ZDHHC1 in DNA-virus-triggered signaling, we examined the
activation of downstream signaling components involved in
virus-triggered type I IFN induction. As shown in Figure 2D,
HSV-1- but not SeV-triggered phosphorylation of TBK1, IRF3,
IkBa, and p38, which are hallmarks of activation of virus-
triggered IFN induction pathways, were markedly lower in
Zdhhc1/ in comparison to Zdhhc1+/+ MEFs. These results
suggest that ZDHHC1 is important for HSV-1- but not SeV-trig-
gered activation of IRF3, NF-kB, and p38, as well as induction of
downstream cytokines and other effecters.
We next determined whether ZDHHC1 is essential for virus-
triggered induction of downstream genes in immune cells. We
obtained mouse bone-marrow-derived macrophages (BMDMs).
As shown in Figure 3A, the levels of Ifnb1, Isg56, and Il6mRNAs
induced by transfected synthetic DNAs, including B-DNA,r Inc.
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Figure 2. ZDHHC1 Is Essential for DNA but
Not RNA Virus-Triggered Signaling in MEFs
(A) Effects of ZDHHC1 deficiency on transcription
of Ifnb1, Isg56, and Il6 induced by transfected
nucleic acids in MEFs. MEFs (2 3 105) were
transfected with the indicated nucleic acids
(3 mg/ml) for 12 hr before qPCR analysis.
(B) Effects of ZDHHC1 deficiency on secretion of
IFN-b, TNFa, and IL6 induced by transfected nu-
cleic acids in MEFs. MEFs (1 3 105) were trans-
fected with the indicated nucleic acids (3 mg/ml) for
24 hr. The culture medium was collected for
quantization of the indicated cytokines by ELISA.
(C) Effects of ZDHHC1 deficiency on HSV-1, SeV-,
and VSV-induced transcription of Ifnb1, Isg56, and
Il6 in MEFs. MEFs (2 3 105) were left untreated or
infected with HSV-1, SeV, or VSV for 5 hr before
qPCR analysis.
(D) ZDHHC1 deficiency impairs HSV-1- but not
SeV-induced phosphorylation of downstream
components. MEFs (23 106) were left untreated or
infected with HSV-1 or SeV for the indicated times
before immunoblot analysis with the indicated
antibodies.
Graphs show mean ± SD, n = 3. See also
Figure S2.
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Zdhhc1/ in comparison to Zdhhc1+/+ BMDMs. ELISA experi-
ments indicated that the levels of secreted IFN-b, TNFa,
and IL6 induced by transfected dsDNA90 and HSV120 but not
poly(I:C) were markedly lower in Zdhhc1/ in comparison
to Zdhhc1+/+ BMDMs (Figure 3B). Additionally, we found that
HSV-1-induced expression of Ifnb1, Isg56, Tnfa, and Il6mRNAs
were markedly decreased in Zdhhc1/ in comparison to
Zdhhc1+/+ BMDMs (Figure 3C). In addition to HSV-1, induction
of Ifnb1, Il6, and Tnfa by another examined DNA virus, ectromelia
virus (ECTV), was also impaired in Zdhhc1/ in comparison
to Zdhhc1+/+ BMDMs (Figure S3). In similar experiments, SeV-Cell Host & Microbe 16, 450–461and VSV-induced expression of Ifnb1,
Isg56, Tnfa, and Il6 mRNAs were similar
in Zdhhc1/ and Zdhhc1+/+ BMDMs
(Figure 3C). Consistently, HSV-1-trig-
gered, but not SeV-triggered, secretion
of cytokines, including IFN-b, TNFa, and
IL6, was decreased in Zdhhc1/ in com-
parison to wild-type BMDMs (Figure 3D).
Thus, ZDHHC1 is essential for DNA-
but not RNA-virus-triggered induction of
downstream genes in mouse BMDMs.
In addition to BMDMs, we found that
transfected synthetic DNAs- or HSV-1-
but not SeV- or VSV-triggered expres-
sion of Ifnb1, Isg56, Tnfa, and Il6 genes
was impaired in mouse bone marrow-
derived DCs of Zdhhc1/ mice (Fig-
ure S4). In contrast, expression of Ifnb1,
Tnfa and Il6 genes was similar between
Zdhhc1/ and Zdhhc1+/+ BMDMs and
DCs following extracellular treatmentwith poly(I:C), a ligand of TLR3 (Figure S5). Taken together, these
results suggest that ZDHHC1 is essential for DNA but not RNA-
virus-triggered induction of downstream genes in mouse im-
mune cells.
ZDHHC1 Is Essential for Host Defense against HSV-1
Infection in Mice
To gain insight into the importance of ZDHHC1 in host defense
against viral infection in vivo, we investigated innate antiviral
immune response in wild-type and ZDHHC1-deficient mice.
We found that serum cytokines induced by HSV-1 infection,
including IFN-b, IFN-a, TNFa and IL6, were severely impaired, October 8, 2014 ª2014 Elsevier Inc. 453
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Figure 3. ZDHHC1 Is Essential for DNAbut Not RNA-Virus-Triggered
Signaling in BMDMs
(A and B) Effects of ZDHHC1 deficiency on expression of the indicated genes
in BMDMs. BMDMs (23 105) were transfectedwith the indicated nucleic acids
(3 mg/ml) and then qRCR (A) or ELISA (B) experiments were performed at 6 or
24 hr after transfection, respectively.
(C) Effects of ZDHHC1 deficiency on HSV-1-, SeV-, and VSV-induced tran-
scription of Ifnb1, Isg56, Tnfa, and Il6 in BMDMs. BMDMs (2 3 105) were
infected with HSV-1 for the indicated times or with SeV/VSV for 5 hr before
qPCR analysis.
(D) Effects of ZDHHC1 deficiency on HSV-1- and SeV-induced secretion of
IFN-b, TNFa, and IL6 in BMDMs. BMDMs (1 3 105) were infected with HSV-1
or SeV for 24 hr. The culture medium was collected for quantization of the
indicated cytokines by ELISA.
Graphs show mean ± SD, n = 3. See also Figures S3, S4, and S5.
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454 Cell Host & Microbe 16, 450–461, October 8, 2014 ª2014 Elseviein Zdhhc1/ in comparison to Zdhhc1+/+ mice (Figure 4A). In
parallel experiments, the serum cytokine levels induced by
VSV infection were similar between Zdhhc1/ and Zdhhc1+/+
mice (Figure 4A). Since HSV-1 is a neurotropic virus and the lead-
ing cause of sporadic viral encephalitis, we investigated the ef-
fects of ZDHHC1-deficiency on HSV-1-induced expression of
downstream genes and viral loads in the brain. The results indi-
cated that after intranasal (i.n.) infection with HSV-1 for 6 days,
the expression of Ifnb1, Isg56, Rantes and Il6 were markedly
reduced whereas the viral titers were significantly increased
in the brain of Zdhhc1/ mice in comparison to their wild-type
counterparts (Figures 4B and 4C). We also compared the sur-
vival rates of Zdhhc1/ and Zdhhc1+/+ mice after HSV-1 infec-
tion intraperitoneally (i.p.) at a high dose (53 107 pfu per mouse).
The results indicated that Zdhhc1/ mice were more suscepti-
bility to HSV-1-triggered death than their wild-type counterparts
(Figure 5D). In parallel experiments, the survival rates were
similar between Zdhhc1/ and Zdhhc1+/+ mice infected with
VSV (Figure 5D). Collectively, these data indicated that ZDHHC1
is essential for the induction of downstream antiviral effecters
and host defense against DNA but not RNA viruses in mice.
ZDHHC1 Is Associated and Colocalized with MITA
To investigate themolecular mechanisms on the role of ZDHHC1
in innate immune response against DNA viruses, we first
determined whether ZDHHC1 is associated with components
involved in virus-triggered signaling pathways. The results indi-
cated that human ZDHHC1 was associated with MITA but not
other examined components including cGAS, IF116, DDX41,
LSm14A, RIG-I, VISA, TBK1, TRAF6 and IRF3 (Figure 5A).
Domain-mapping experiments indicated that the N terminus of
MITA (aa1-190) and the N terminus of ZDHHC1 (aa1-271), both
contain multiple transmembrane domains of the respective pro-
teins, were required for their association (Figure 5B). Since
ZDHHC1 and MITA are highly expressed in THP1 cells (Figures
S1F and S1G), and knockdown of ZDHHC1 inhibited HSV-1-trig-
gered expression of IFNB1, TNFA and IL6 in these cells (Fig-
ure S6), we determined whether ZDHHC1 is associated with
MITA in these cells. Endogenous coimmunoprecipitation exper-
iments indicated that ZDHHC1 was associated with MITA in
THP1 cells and this association was not affected following
HSV-1 infection (Figure 6C). In these experiments, ZDHHC1
was not associated with AMFR/gp78, an abundant ER mem-
brane protein that is involved in the final step of endoplasmic
reticulum-associated degradation (ERAD) (Chen et al., 2012).
Previously, it has been demonstrated that MITA is localized at
the ER and mitochondria. It has also been shown that sensing of
viral DNA results in translocation of MITA to Golgi apparatus and
eventually to cytoplasmic puncture structures (Burdette and
Vance, 2013; Paludan and Bowie, 2013; Saitoh et al., 2009; Sai-
toh et al., 2010). Since ZDHHC1 contains four transmembrane
domains and associates with MITA through their respective
N-terminal transmembrane domains, we examined whether
ZDHHC1 and MITA colocalize in the cell. Confocal microscopy
experiments indicated that ZDHHC1 was colocalized with
MITA before and after HSV-1 infection (Figure 5D). ZDHHC1
was mostly localized at the ER and Golgi apparatus but barely
at mitochondria (Figure 5E). Interestingly, it seems that more
ZDHHC1 was localized at the Golgi apparatus after HSV-1r Inc.
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Figure 4. ZDHHC1 Is Essential for Host
Defense against HSV-1 Infection
(A) Zdhhc1/ and Zdhhc1+/+ mice were infected
i.p. with HSV-1 at 1 3 107 pfu per mouse (n = 10/
11; 8 weeks old) and VSV at 13 107 pfu per mouse
(n = 5; 8 weeks old) for 6 hr, followed by mea-
surement of the indicated serum cytokines by
ELISA.
(B) Zdhhc1/ and Zdhhc1+/+ were infected i.n.
with HSV- 1 at 1 3 106 pfu per mouse (n = 5;
8 weeks old), and brains were retrieved after
6 days for HSV-1 plaque assays. The viral titer was
recorded as pfu per gram of brain.
(C) Zdhhc1/ and Zdhhc1+/+ were infected i.n.
with HSV-1 at 1 3 106 pfu per mouse (n = 5;
8 weeks old), and brains were retrieved after
6 days for qPCR analysis.
(D) Zdhhc1/ and Zdhhc1+/+ mice were infected
i.p. with HSV-1 at 5 3 107 pfu per mouse or with
VSV at 23 107 pfu permouse (n = 10; 8 weeks old).
The survival of infected mice was monitored for
15 days.
*p < 0.05; **p < 0.01 (Student’s t test). The survival
curve was generated by Kaplan-Meier methods
followed by log-rank test analysis.
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and MITA are physically associated with each other.
ZDHHC1 Modulates MITA Activity
Since ZDHHC1 is physically associated with MITA, we next
determined whether ZDHHC1 regulates MITA activity. Previous
studies indicate that cGAS is an universal sensor of viral DNA
(Li et al., 2013; Sun et al., 2013), and this sensing leads to pro-
duction of cGAMP, which is a high affinity ligand for MITA
(Ouyang et al., 2012; Wu et al., 2013; Xiao and Fitzgerald,
2013; Zhang et al., 2013). In reporter assays, transfection of B-
DNA, cGAMP, cGAS,MITA or ZDHHC1 alone barely or onlymini-
mally activated the IFN-b promoter. Co-expression of MITA and
ZDHHC1 weakly activated the IFN-b promoter, whereas MITACell Host & Microbe 16, 450–461combines with an upstream signal, such
as B-DNA, cGAMP or cGAS, activated
the IFN-b promoter to a higher degree
(Figure 6A). Importantly, ZDHHC1 greatly
potentiated activation of the IFN-b pro-
moter triggered by the combination of
MITA and an upstream component such
as B-DNA, cGAMP or cGAS (Figure 6A).
Furthermore, knockdown of MITA in-
hibited ZDHHC1- and B-DNA-triggered
activation of the IFN-b promoter (Fig-
ure 6B), whereas knockdown of ZDHHC1
inhibited B-DNA-, cGAMP plus MITA-
but not MITA-triggered activation of the
IFN-b promoter (Figure 6C). In addition,
cGAMP- or c-di-GMP-induced transcrip-
tion of Ifnb1, Isg56, Tnfa and Il6 was
impaired in Zdhhc1/ in comparison to
Zdhhc1+/+ DCs, MEFs and BMDMs
(Figures 6D and S7). Similarly, cGAMP-triggered production of cytokines, including IFN-b, TNFa and
IL6, was also inhibited in Zdhhc1/ cells (Figures 6D and S7).
Collectively, these results suggest that ZDHHC1 functions
downstream of cGAMP to modulate MITA activity.
Previously, it has been shown that dimerization and aggrega-
tion of MITA is important for its activation after viral DNA sensing,
which leads to its recruitment of downstream components TBK1
and IRF3 (Ouyang et al., 2012; Tanaka and Chen, 2012; Yin et al.,
2012; Zhang et al., 2013). We found that knockdown of ZDHHC1
caused decreased dimerization of MITA (Figure 7A). Further-
more, we determined whether ZDHHC1 deficiency affects the
dimerization and aggregation of MITA. As shown in Figure 7B,
aggregation of MITA induced by HSV-1 or cGAMP was
decreased in Zdhhc1/ in comparison to Zdhhc1+/+ DCs., October 8, 2014 ª2014 Elsevier Inc. 455
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Figure 5. ZDHHC1 Is Associated and Colocalized with MITA
(A) ZDHHC1 is associated with MITA. The 293 cells (23 106) were transfected with the indicated plasmids (5 mg each). Coimmunoprecipitation and immunoblot
were performed with the indicated antibodies.
(B) Domain mapping of ZDHHC1-MITA association. In the left panel, the experiments were performed similarly as in (A). The right panel shows schematic
representations of MITA and ZDHHC1 proteins.
(legend continued on next page)
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aa232. The prevalent variant contains an arginine (R) whereas a
rare variant contains a histidine (H) (Diner et al., 2013; Zhang
et al., 2013). Crystal structure studies have demonstrated that
R232 from a b sheet of MITA is involved in its binding to cyclic
dinucleotides, and is important for the conformational change
and functional activation of dimerized MITA (Burdette and
Vance, 2013; Zhang et al., 2013). Functional studies have shown
that cGAMP potentiates MITA(R232) but not MITA(H232)-medi-
ated induction of IFN-b (Diner et al., 2013; Zhang et al., 2013).
Interestingly, we confirmed that cGAMP could potentiate
MITA(R232)- but not MITA(H232)-mediated activation of the
IFN-b promoter (Figure 7C). However, ZDHHC1 could potentiate
both MITA(R232)- and MITA(H232)-mediated activation of the
IFN-b promoter (Figure 7C). This data support the hypothesis
that ZDHHC1 is important for cGAMP-induced dimerization/
aggregation and activation of MITA. Consistently, we found
that recruitment of TBK1 and IRF3 to MITA after HSV-1 infec-
tion was markedly decreased in Zdhhc1/ in comparison to
Zdhhc1+/+ bone-marrow-derived DCs (Figure 7D). These results
suggest that ZDHHC1 is important for the activation of MITA.
DISCUSSION
In recent years, how DNA viruses trigger innate immune
response has been extensively investigated. Several recent
breakthroughs have helped to outline a model on the induction
of type I IFNs triggered by DNA viruses. In this model, cGAS
serves as a sensor for viral DNA (Civril et al., 2013; Li et al.,
2013; Sun et al., 2013). Upon binding of viral DNA, cGAS cata-
lyzes the production of the second messenger molecule
cGAMP, which binds to the adaptor protein MITA (Sun et al.,
2013; Wu et al., 2013; Zhang et al., 2013). This induces the
dimerization/aggregation and activation of MITA, which in turn
recruits downstream TBK1 and IRF3, leading to induction of
type I IFN genes (Tanaka and Chen, 2012; Zhong et al., 2008).
In this study, we have utilized expression screens to identify
ZDHHC1 as a mediator of DNA-virus-triggered IFN induction.
There are several lines of evidences suggesting that ZDHHC1
is important for innate immune response against DNA viruses.
First, overexpression of ZDHHC1 activated the promoter of
IFN-b and potentiated viral DNA-triggered activation of the
IFN-b promoter. Second, induction of type I IFNs (IFN-b and
IFN-a) and proinflammatory cytokines (TNFa and IL6) was
impaired in Zdhhc1/ MEFs, mouse BMDMs, and DCs upon
infection with the DNA viruses HSV-1 and ECTV but not with
the RNA viruses SeV and VSV. Third, serum cytokines (IFN-b,
IFN-a, TNFa, and IL6) induced by HSV-1 infection were severely
impaired in Zdhhc1/ in comparison to Zdhhc1+/+ mice. In
similar experiments, the serum cytokine levels induced by VSV
infection were similar between Zdhhc1/ and Zdhhc1+/+ mice.(C) Endogenous ZDHHC1 is associated with MITA in THP1 cells. THP1 cells (
Coimmunoprecipitation experiments were performed with anti-ZDHHC1, and the
KDEL (which recognizes AMFR/gp78). The lysates were analyzed by immunoblo
(D and E) Colocalization of ZDHHC1 andMITA with the ER andGolgi. HeLa cells (1
Sec61b (ER marker) or GFP-Galt (Golgi marker), respectively. Twenty hours afte
confocal microscopy.
See also Figure S6.
Cell HosForth, expression of Ifnb1, Isg56, Rantes, and Il6 were markedly
reduced, whereas the viral titers were significantly increased in
the brain of Zdhhc1/ mice in comparison to their wild-type
counterparts. In addition, Zdhhc1/ mice were more suscepti-
bility to HSV-1-triggered death than their wild-type counterparts.
Collectively, these results suggest that ZDHHC1 is essential
for efficient induction of downstream antiviral effecters and
host defense against DNA but not RNA viruses in mice.
MITA is an adaptor protein essential for DNA-virus-triggered
induction of type I IFNs and proinflammatory cytokines (Ishikawa
and Barber, 2008; Ishikawa et al., 2009; Zhong et al., 2008). Our
studies suggest that the role of ZDHHC1 in innate immune
response against DNA viruses is mediated by its physical and
functional association with MITA. Similar to MITA, ZDHHC1 con-
tains four N-terminal transmembrane domains and is predomi-
nantly localized at the ER. Coimmunoprecipitation experiments
indicated that ZDHHC1 was constitutively associated with
MITA before and after HSV-1 infection and this association
wasmediated by their respective N-terminal transmembrane do-
mains. Confocal microscopy experiments indicate that ZDHHC1
was colocalized with MITA at the ER and both proteins were
translocated to the Golgi apparatus and cytoplasmic puncture
structures upon HSV-1 infection in HeLa cells.
In addition to a physical association between ZDHHC1 and
MITA, several lines of results suggest that ZDHHC1 acts in innate
antiviral response by modulating the activity of MITA. First,
ZDHHC1 greatly potentiated activation of the IFN-b promoter
triggered by the combination of MITA and an upstream compo-
nent such as B-DNA, cGAMP, or cGAS. Second, knockdown of
MITA inhibited ZDHHC1- and B-DNA-triggered activation of the
IFN-b promoter, whereas knockdown of ZDHHC1 inhibited
B-DNA-, cGAMP plus MITA-, but not MITA-triggered activation
of the IFN-b promoter. Third, cGAMP- or c-di-GMP-induced
expression of Ifnb1, Isg56, Tnfa, and Il6 was impaired in
Zdhhc1/ in comparison to Zdhhc1+/+ cells. Forth, cGAMP
potentiated MITA(R232)- but not MITA(H232)-mediated induc-
tion of IFN-b, whereas ZDHHC1 potentiated both MITA(R232)-
and MITA(H232)-mediated induction of IFN-b. Fifth, knockdown
of ZDHHC1 caused decreased dimerization of MITA, whereas
the aggregation of MITA as well as the recruitment of TBK1
and IRF3 to MITA after HSV-1 infection wasmarkedly decreased
in Zdhhc1/ in comparison to Zdhhc1+/+ DCs. Collectively,
these results support the hypothesis that ZDHHC1 is important
for cGAMP-induced dimerization/aggregation and activation of
MITA upon infection of DNA viruses.
Several studies have demonstrated that MITA is involved in
IFN-b induction triggered by poly(I:C) and RNA viruses in certain
human cell lines including 293 and HeLa cells (Ishikawa and
Barber, 2008; Sun et al., 2009; Zhong et al., 2008). In addition,
studies with cGas/ cells and mice suggest that cGAS also
plays a role in innate immune response against the ssRNA virus5 3 107) were left untreated or infected with HSV-1 for the indicated times.
immunoprecipitates were analyzed by immunoblots with anti-MITA and anti-
ts with the indicated antibodies.
3 105) were transfected with GFP-MITA and ZDHHC1-Cherry, as well as GFP-
r transfection, cells were left untreated or infected with HSV-1 for 4 hr before
t & Microbe 16, 450–461, October 8, 2014 ª2014 Elsevier Inc. 457
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Figure 6. ZDHHC1 Signals through MITA
(A) Effects of ZDHHC1 on activation of the IFN-b promoter mediated by MITA
and upstream components. The 293 cells (1 3 105) were transfected with the
IFN-b promoter plasmid (0.1 mg) and the indicated plasmids (0.1 mg) for 20 hr or
were further transfectedwith B-DNA (0.5 mg) or cGAMP (0.5 mg) for 16 hr before
luciferase assays were performed.
(B) Knockdown of MITA inhibits ZDHHC1-, B-DNA-, and ZDHHC1+B-DNA-
induced activation of the IFN-b promoter. The 293 cells (1 3 105) were first
transfected with a control or two independentMITA-RNAi plasmids (1 mg). One
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overexpression of ZDHHC1 potentiated activation of the IFN-b
promoter triggered by transfected poly(I:C) or SeV infection,
whereas knockdown of ZDHHC1 inhibited activation of the
IFN-b triggered by transfected poly(I:C) or SeV infection in
HeLa cells. It is possible that, similar as MITA, ZDHHC1 is also
involved in RNA-virus-triggered signaling in some human cell
lines. This again further supports a physical and functional asso-
ciation between ZDHHC1 and MITA.
Previously, it has been demonstrated that cytokine production
triggered by HSV-1 infection is almost completely abolished in
Mita/ cells (Ishikawa and Barber, 2008; Ishikawa et al., 2009;
Li et al., 2013), which we confirmed (Figure S7C). In this context,
it is noticed that cytokine production triggered by HSV-1 in
Zdhhc1/cellsandmicewas reduced to20%–50%incompar-
ison to thewild-type counterparts. Similar observations were also
found for cytokine production triggered by cGAMP or c-di-cGMP
in Zdhhc1/ and Zdhhc1+/+ MEFs, BMDMs, and DCs. Based on
these observations as well as the notion that cGAMP directly
binds to MITA, we hypothesize that ZDHHC1 functions as an
amplifier for MITA-mediated innate antiviral response. Alterna-
tively, since ZDHHC1 is a member of the DHHC palmitoyl trans-
ferase family, it is possible that another member of the family
may play a redundant role in MITA-mediated innate antiviral
response. Nevertheless, modulation of MITA-mediated signaling
by ZDHHC1 provides insight into the complicated and delicate
mechanisms on innate antiviral response against DNA viruses.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
Poly(I:C), 3030-cGAMP, and c-di-GMP (InvivoGen); GM-CSF (peproTech);
lipofectamine 2000, and dual-specific luciferase assay kit (Promega); ELISA
kit for murine IFN-a and IFN-b (PBL); ELISA kit for murine TNFa and IL6
(Biolegend); mouse antibodies against Flag, b-actin (Sigma), phospho-IkBa,
p38, phospho-p38 (CST), and HA (Covance); rabbit polyclonal antibodies
against ZDHHC1 (Abcam), KDEL, IRF3 and phospho-IRF3, p65 (Santa
Cruz Biotechnology), cGAS/C6orf150 (AVIVA Systems Biology), TBK1, and
phospho-TBK1(EPITOMICS) were purchased from the indicated manufac-
turers. SeV, VSV, HSV-1, and anti-MITA sera were previously described (Li
et al., 2012; Zhong et al., 2008). HEK293, HeLa, and THP1 cells were obtained
from ATCC. HEK293T cells were originally provided by Dr. Gary Johnson
(National Jewish Health). Mita/ mice were generated by conventional gene
knockout procedures.
Expression Cloning
The cDNA expression clones encoding 10,000 independent human cDNAs
was obtained from Origene. The clones were individually transfected intoday later, cells were selected with puromycin (1 mg/ml) for 24 hr and then
retransfected with the IFN-b promoter reporter and ZDHHC1 expression
plasmid (0.1 mg each) or B-DNA (3 mg/ml). Luciferase assays were performed
24 hr after retransfection. The efficiencies of MITA-RNAi plasmids were shown
by immunoblots (left panels).
(C) Knockdown of ZDHHC1 inhibits B-DNA and MITA+cGAMP but not MITA-
mediated activation of the IFN-b promoter. The experiments were similarly
performed as in (B).
(D) Effects of ZDHHC1 deficiency on cGAMP-induced expression of the
indicated genes. DCs were treated with cGAMP (100 nM) in digitonin per-
meabilization solution at 37C for 30 min. The cells were then incubated in
regular medium for 4 or 12 hr before qPCR or ELISA experiments were per-
formed respectively.
See also Figure S7.
r Inc.
A B
C D
Figure 7. ZDHHC1 Modulates MITA Activity
(A) Knockdown of ZDHHC1 impairs dimerization
of MITA. The 293 cells (2 3 106) were trans-
fected with a control or ZDHHC1-RNAi plasmid
(10 mg). Twelve hours after transfection, cells were
selected with puromycin (1 mg /ml) for 24 hr,
then further transfected with FLAG-MITA and HA-
MITA for 20 hr before coimmunoprecipitation and
immunoblot analysis were performed.
(B) ZDHHC1 deficiency impairs aggregation of
MITA induced by HSV-1 or cGAMP. DCs (23 107)
were infected with HSV-1 for the indicated times
(left panels) or treated with cGAMP (100 nM) in
control or digitonin-containing solution for 1 hr
(right panels). Cell lysates were separated by
native or SDS PAGE as indicated and analyzed by
immunoblots with the indicated antibodies.
(C) ZDHHC1 potentiates both MITA(R232)- and
MITA(H232)-mediated activation of the IFN-b
promoter. The 293 cells (13 105) were transfected
with the IFN-b promoter plasmid (0.1 mg) and the
indicated plasmids (0.1 mg) for 20 hr or were further
transfected with cGAMP (0.5 mg) for 16 hr before
luciferase assays were performed.
(D) ZDHHC1 deficiency impairs HSV-induced
recruitment of TBK1 and IRF3 to MITA. DCs (5 3
107) from Zdhhc1/ and Zdhhc1+/+ mice were
left untreated or infected with HSV-1 for the indi-
cated times. Coimmunoprecipitation and immu-
noblot analysis were performed with the indicated
antibodies.
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luciferase assays.
Constructs
IFN-b, ISRE, and NF-kB luciferase reporter plasmids; mammalian expression
plasmids for HA-, Flag-tagged MITA, and its mutants; and RIG-I, MDA5, VISA,
TBK1, and IRF3 were previously described (Xu et al., 2005; Zhong et al., 2008).
The pCMV-ERIS/MITA-HA plasmid was provided by Dr. Zhengfan Jiang
(Peking University). pcDNA3.1-Flag-cGAS was provided by Dr. Zhijian Chen
(University of Texas Southwestern Medical Center); Flag-tagged DDX41,
IFI16, human andmurine ZDHHC1, and human ZDHHC1 truncations and point
mutants were constructed by standard molecular biology techniques.
DNA Oligonucleotides
The following oligonucleotides were used to stimulate cells:
poly(dG:dC): 50-CCGCCAGCCCGCGGGCTGGCGCCCCCACTCGGGCCG
TCGGGGCCGCGCCTCCCCCGCGAGGCCGCCGGCG-30;
dsDNA90: 50-TACAGATCTACTAGTGATCTATGACTGATCTGTACATGATC
TACATACAGATCTACTAGTGATCTATGACTGATCTGTACATGATCTACA-30;
HSV120:
50-AGACGGTATATTTTTGCGTTATCACTGTCCCGGATTGGACACGGTCTT
GTGGGATAGGCATGCCCAGAAGGCATATTGGGTTAACCCCTTTTTATTTGT
GGCGGGTTTTTTGGAGGACTT-30;
B-DNA: dsDNA with a sequence of poly(dA-dT)$poly(dT-dA).
Transfection and Reporter Assays
HEK293 cells were transfected by standard calcium phosphate precipitation
method. HeLa cells and MEFs were transfected by lipofectamine 2000. To
normalize for transfection efficiency, 0.01 mg of pRL-TK (Renilla luciferase)
reporter plasmid was added to each transfection. Luciferase assays were per-
formed using a dual-specific luciferase assay kit.
RNAi
Double-stranded oligonucleotides corresponding to the target sequences
were cloned into the pSuper.Retro-RNAi plasmid (Oligoengine). The following
sequences were targeted for ZDHHC1 mRNA: #1-AGGTGGAGTGGGATACell HosGAAA; #2-GTGGAGTGGGATAGAAAGA. MITA-RNAi was as previously
described (Zhong et al., 2008).
RNAi-Transduced Stable THP-1 Cells
The 293 cells were transfected with two packaging plasmids (pGAG-Pol and
pVSV-G) together with a control or ZDHHC1-RNAi retroviral plasmid.
Twenty-four hours later, cells were incubated with new medium without
antibiotics for another 24 hr. The recombinant virus-containing medium
was filtered and then added to THP-1 cells in the presence of polybrene
(8 mg/ml). The infected cells were selected with puromycin (0.5 mg/ml) for
7 days before additional experiments.
Coimmunoprecipitation and Immunoblot Analysis
HEK293 cells (5 3 106), THP1 or DCs (5 3 107) were lysed in l ml NP-40 lysis
buffer (20 mM Tris$HCl [pH 7.4], 150mMNaCl, 1 mMEDTA, 1%Nonidet P-40,
10 mg/ml aprotinin, 10 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluo-
ride). Coimmunoprecipitation and immunoblot analysis were performed as
previously described (Xu et al., 2005).
Generation and Phenotyping of Zdhhc1 Knockout Mice
Strategy of construction of the targeting vector is illustrated in Fig-
ure S2A. The linearized targeting vector was electroporated into W4 ES
cells, which was then selected in G418 medium. One positive clone was in-
jected into 129S6/SvEvTac blastocysts. Genotyping by PCR was performed
using a combination of the following primers: #1-GAGTGTATAGCCCCT
GCCAGT, #2-CAACCCTGCACTACCTCACATG, and #3-CTCGAGGGGAT
CCACTAGTTC. Amplification of the wild-type allele with primers #1 and
#2 results in a 459-bp fragment, whereas amplification of the disrupted
allele with primers #2 and #3 results in a 264-bp fragment. The primers
used for RT-PCR analysis of murine Zdhhc1 mRNA are as follows:
ATGAACATCTGCAACAAACCC (forward) and ATGGTGATCGAAGCCGCA
TAC (reverse).
Preparations of MEFs, BMDMs, and DCs
MEFs were prepared from day 13.5 embryos and cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovinet & Microbe 16, 450–461, October 8, 2014 ª2014 Elsevier Inc. 459
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of BMDMs, the bone marrow cells were cultured in 10% M-CSF-containing
conditional medium from L929 cells for 3–5 days. For preparation of DCs,
the bone marrow cells were cultured in medium containing murine GM-CSF
(50 ng/ml) and IL-4 (10 ng/ml) for 6–9 days.
Real-Time PCR
Total RNA was isolated for real-time PCR analysis to measure mRNA levels
of the indicated genes. Data shown are the relative abundance of the indi-
cated mRNA normalized to that of Gapdh. Primer sequences for Ifnb1,
Rantes, Isg56, Tnfa, Il6, and Gapdh were as previously reported (Li et al.,
2012).
Viral Infection in Mice
Mice were infected with HSV-1 or VSV i.p. or i.n. The viability of the infected
mice was monitored for 15 days. The mouse serum was collected at 6 hr after
infection to measure cytokine production by ELISA. Viral infection in mice was
carried out in an ABSL-2 facility, and the protocols and procedures for mice
study were approved by the Institutional Review Board of Wuhan Institute of
Virology (WIVA31201301).
Viral Plaque Assay
Brains were weighed and homogenized for 3 s in DMEM medium. After
homogenization, the brain suspensions were centrifuged at 1,620 3 g for
30 min, and the supernatants were used for plaque assays on monolayers
of Vero cells seeded in 24-well plates. The cells were infected by incubation
for 1 hr at 37C with serial dilutions of brain suspensions. After 1 hr infection,
2% methylcellulose was overlaid, and the plates were incubated for about
48 hr. The overlay was removed, and cells were fixed with 4% paraformalde-
hyde for 15 min and stained with 1% crystal violet for 30 min before plaque
counting.
Fluorescent Confocal Microscopy
HeLa cells were transfectedwith the indicated plasmids by lipofectamine 2000
(Invitrogen). At 20 hr after transfection, the cells were infected with HSV-1 for
4 hr and then fixed with 4%paraformaldehyde for 10min at room temperature.
The cells were observed with an Olympus confocal microscope under a 1003
oil objective.
Flow Cytometry
Spleen, thymus, and peripheral lymph nodes were obtained from Zdhhc1+/+
and Zdhhc1/mice, and single-cell suspensions were prepared. After deple-
tion of red blood cells by ammonium chloride, cells were subject to staining
with the indicated antibodies for 15 min followed by flow analysis. The anti-
bodies used in this study were CD4-PerCP (BD), CD8-FITC (BD), CD3- FITC
(BD), CD19-PE (BD), CD11c-PE (BD), and CD11b-FITC (BD).
Digitonin Permeabilization of Mouse DCs and BMDMs
DCs or BMDMs were treated with cGAMP (100 nM) in digitonin permeabili-
zation solution (50 mM HEPES [pH 7.0], 100 mM KCl, 3 mM MgCl2,
0.1 mM DTT, 85 mM sucrose, 0.2% BSA, 1 mM ATP, 0.1 mM GTP, and
10 mg/ml digitonin) at 37C for 30 min. The cells were then incubated in
regular medium for 4 or 12 hr before qPCR or ELISA experiments were per-
formed, respectively.
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